Clinic-based evaluation of a point-of-care creatinine assay to screen for renal impairment amongst HIV-positive patients receiving tenofovir disoproxil fumarate

Lignende værker

• Safety of coitally administered tenofovir 1% gel, a vaginal microbicide, in chronic hepatitis B virus carriers: Results from the CAPRISA 004 trial
  af: BAXTER, Cheryl, et al.
  Udgivet: (2013)
• Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
  af: Bukkems, Vera E., et al.
  Udgivet: (2020)
• Increased tenofovir monoester concentrations in patients receiving tenofovir disoproxil fumarate with ledipasvir/sofosbuvir
  af: Brooks, Kristina M, et al.
  Udgivet: (2019)
• A drug evaluation of 1% tenofovir gel and tenofovir disoproxil fumarate tablets for the prevention of HIV infection
  af: Gengiah, Tanuja N, et al.
  Udgivet: (2012)
• Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine
  af: Dumond, Julie B., et al.
  Udgivet: (2020)